6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside manufacturers
|
| | 6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside Basic information |
| Product Name: | 6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside | | Synonyms: | 6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside;6-chloro-purine-9-beta-D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside;6-Chloro-purine-9-β-D-(2-O-acetyl-3,5-di-O-benzoyl)xylofuranoside;6-chloro-purine-9-b-D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside;9H-Purine, 9-(2-O-acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-;9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloropurine | | CAS: | 132370-61-7 | | MF: | C26H21ClN4O7 | | MW: | 536.93 | | EINECS: | | | Product Categories: | | | Mol File: | 132370-61-7.mol |  |
| | 6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside Chemical Properties |
| Boiling point | 697.5±65.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | pka | 0.76±0.10(Predicted) |
| | 6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside Usage And Synthesis |
| Uses | 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 6-chloro-purine-9--D-(2-O-acetyl-3,5-di-O-benzoyl)xylo-furanoside Preparation Products And Raw materials |
|